Showing results (271-280 of 382) with videos related to

Sort By:
Pageof 39
Biorxiv : the Preprint Server for Biology|September 5, 2025
CCAAT-enhancer binding protein delta functions as a tumor suppressor gene in acute myeloid leukemiaSubhash C Prajapati, Cem Meydan, Yaseswini Neelamraju, et al.
The Journal of Clinical Investigation|November 11, 2014
GP130 activation induces myeloma and collaborates with MYCTobias Dechow, Sabine Steidle, Katharina S Götze, et al.
The Journal of Experimental Medicine|March 21, 2019
Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AMLFaisal Basheer, George Giotopoulos, Eshwar Meduri, et al.
Blood|January 6, 2026
Clonal Hematopoiesis and Lymphoma-Associated Mutations in Hematopoietic Progenitors in B-Cell Non-Hodgkin LymphomaLaura Wiegand, Patricia Silva, Daniel Noerenberg, et al.
Haematologica|February 13, 2023
General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemiaNicola Gökbuget, Kristina Ihrig, Michael Stadler, et al.
Leukemia & Lymphoma|November 4, 2014
Up-regulated MSI2 is associated with more aggressive chronic myeloid leukemiaJaspal Kaeda, Frauke Ringel, Christian Oberender, et al.
Blood|November 24, 2020
Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomasMaurice Reimann, Jens Schrezenmeier, Paulina Richter-Pechanska, et al.
The Lancet. Oncology|September 7, 2019
Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trialJohannes Weller, Theophilos Tzaridis, Frederic Mack, et al.
British Journal of Haematology|October 11, 2014
Targeted sequencing using a 47 gene multiple myeloma mutation panel (M(3) P) in -17p high risk diseaseKlaus M Kortüm, Christian Langer, Jorge Monge, et al.
Blood|December 22, 2011
TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcomeFrank G Rücker, Richard F Schlenk, Lars Bullinger, et al.
Pageof 39